TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 199 filers reported holding TG THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,081 | +1045.2% | 165,414 | +672.4% | 0.66% | +804.1% |
| Q1 2023 | $531 | -90.3% | 21,415 | -20.3% | 0.07% | -91.2% |
| Q4 2022 | $5,498 | -99.9% | 26,856 | -98.2% | 0.83% | -48.6% |
| Q3 2022 | $10,696,000 | +677.9% | 1,469,283 | +3015.0% | 1.62% | +562.0% |
| Q2 2022 | $1,375,000 | -70.7% | 47,168 | -5.5% | 0.24% | -68.1% |
| Q1 2022 | $4,690,000 | -3.3% | 49,926 | +1318.4% | 0.77% | -7.0% |
| Q4 2021 | $4,848,000 | -5.9% | 3,520 | -91.3% | 0.83% | +32.5% |
| Q3 2021 | $5,151,000 | +172.7% | 40,321 | +49.8% | 0.62% | +184.9% |
| Q2 2021 | $1,889,000 | +22.6% | 26,923 | -15.8% | 0.22% | -19.5% |
| Q1 2021 | $1,541,000 | -5.9% | 31,975 | +1.6% | 0.27% | +37.4% |
| Q4 2020 | $1,637,000 | – | 31,473 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 726,200 | $3,086,000 | 3.46% |
| Paradigm Biocapital Advisors LP | 1,964,709 | $8,350,000 | 1.66% |
| 683 Capital Management, LLC | 3,300,000 | $14,025,000 | 0.99% |
| MAVERICK CAPITAL LTD | 6,747,549 | $28,677,000 | 0.71% |
| Antara Capital LP | 1,500,000 | $6,375,000 | 0.27% |
| Parkwood LLC | 47,168 | $1,375,000 | 0.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,677,500 | $11,379,000 | 0.24% |
| PURA VIDA INVESTMENTS, LLC | 950,813 | $4,041,000 | 0.24% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 567,576 | $2,412,000 | 0.20% |
| Antara Capital LP | 900,000 | $3,825,000 | 0.16% |